Patent ID: 8658179
Filing Date: 2014-02-25
Classification: A61K,A61P,C07K

Abstract:
1. An isolated glycoconjugate that comprises: a first domain that is a ligand for a receptor on a bacterial pathogen or an amino acid sequence of an antibody that binds a bacterial pathogen; and a second domain that has at least one Gal α(1,3)Gal saccharide synthetically conjugated to said ligand or said amino acid sequence of an antibody, wherein said at least one Gal α(1,3)Gal saccharide is directly joined to the first domain at one amino acid, wherein said first domain is configured to bind to said bacterial pathogen while said second domain binds to said anti-gal antibody thereby generating a complex that comprises said anti-gal antibody, said glycoconjugate, and said bacterial pathogen.